Literature DB >> 12010486

Effects of irradiation on Plasmodium falciparum sporozoite hepatic development: implications for the design of pre-erythrocytic malaria vaccines.

O Silvie1, J P Semblat, J F Franetich, L Hannoun, W Eling, D Mazier.   

Abstract

Immunization with irradiation-attenuated Plasmodium sporozoites confer protection against live sporozoite challenge. Protection relies primarily on cytotoxic lymphocyte activity against infected hepatocytes, and is suppressed when sporozoites are over-irradiated. Here, we demonstrate that over-irradiated (25-30 krad) Plasmodium falciparum sporozoites invade human hepatocytes and transform into uninucleate liver-trophozoites with the same efficiency as non-irradiated and irradiation-attenuated (12-15 krad) sporozoites. Since hepatocytes infected with over-irradiated non-protective sporozoites are likely to express sporozoite-derived peptide/major histocompatibility complex class I molecules on their surface, our results strongly suggest that sporozoite proteins are not the main immunogens involved in protection, and thus may not per se constitute proper malaria vaccine candidates.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12010486     DOI: 10.1046/j.1365-3024.2002.00450.x

Source DB:  PubMed          Journal:  Parasite Immunol        ISSN: 0141-9838            Impact factor:   2.280


  33 in total

1.  Transcription status of vaccine candidate genes of Plasmodium falciparum during the hepatic phase of its life cycle.

Authors:  Myriam Bodescot; Olivier Silvie; Anthony Siau; Philippe Refour; Paco Pino; Jean-François Franetich; Laurent Hannoun; Robert Sauerwein; Dominique Mazier
Journal:  Parasitol Res       Date:  2004-02-12       Impact factor: 2.289

2.  Laser mimicking mosquito bites for skin delivery of malaria sporozoite vaccines.

Authors:  Chang Zhou; Xinyuan Chen; Qi Zhang; Ji Wang; Mei X Wu
Journal:  J Control Release       Date:  2015-02-25       Impact factor: 9.776

Review 3.  Looking under the skin: the first steps in malarial infection and immunity.

Authors:  Robert Ménard; Joana Tavares; Ian Cockburn; Miles Markus; Fidel Zavala; Rogerio Amino
Journal:  Nat Rev Microbiol       Date:  2013-10       Impact factor: 60.633

Review 4.  Induction and maintenance of protective CD8+ T cells against malaria liver stages: implications for vaccine development.

Authors:  Sze-Wah Tse; Andrea J Radtke; Fidel Zavala
Journal:  Mem Inst Oswaldo Cruz       Date:  2011-08       Impact factor: 2.743

Review 5.  Live attenuated pre-erythrocytic malaria vaccines.

Authors:  Gladys J Keitany; Marissa Vignali; Ruobing Wang
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

6.  Advances and challenges in malaria vaccine development.

Authors:  Ruobing Wang; Joseph D Smith; Stefan H I Kappe
Journal:  Expert Rev Mol Med       Date:  2009-12-16       Impact factor: 5.600

7.  Why functional pre-erythrocytic and bloodstage malaria vaccines fail: a meta-analysis of fully protective immunizations and novel immunological model.

Authors:  D Lys Guilbride; Pawel Gawlinski; Patrick D L Guilbride
Journal:  PLoS One       Date:  2010-05-19       Impact factor: 3.240

8.  Transcriptional analysis of the pre-erythrocytic stages of the rodent malaria parasite, Plasmodium yoelii.

Authors:  Calvin T Williams; Abdu F Azad
Journal:  PLoS One       Date:  2010-04-21       Impact factor: 3.240

9.  Prolonged antigen presentation is required for optimal CD8+ T cell responses against malaria liver stage parasites.

Authors:  Ian A Cockburn; Yun-Chi Chen; Michael G Overstreet; Jason R Lees; Nico van Rooijen; Donna L Farber; Fidel Zavala
Journal:  PLoS Pathog       Date:  2010-05-06       Impact factor: 6.823

10.  Characterization of immunoglobulin G antibodies to Plasmodium falciparum sporozoite surface antigen MB2 in malaria exposed individuals.

Authors:  Thanh V Nguyen; John B Sacci; Patricia de la Vega; Chandy C John; Anthony A James; Angray S Kang
Journal:  Malar J       Date:  2009-10-23       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.